How to implant leadless pacemakers and mitigate major complications

Leadless pacemakers (LPs) were introduced into clinical practice in 2016 when the Micra LP received Food and Drug Administration approval. Since then, .150,000 Micra LPs have been implanted worldwide. In April 2022, the Aveir LP was Food and Drug Administration approved. Implantation of these LPs requires a special set of skills that is different from the skill set required for the implantation of traditional pacemakers. In this hands-on article, we detail the steps required for LP implantation while focusing on mitigating major complications.

Automated summary

Leadless pacemakers (LPs) have been used in clinical practice since 2016, with the Micra LP receiving FDA approval. Over 150,000 Micra LPs have been implanted worldwide. In April 2022, the Aveir LP was also approved by the FDA. The implantation of LPs requires a specific set of skills different from traditional pacemakers, and this article focuses on detailing the steps and mitigating major complications.